Two-years' experience with a Canadian hospital-based autologous blood donor programme.
Two years' experience with a hospital-based autologous blood donor programme is described. Of 511 patients enrolled, 86% underwent surgery without use of allogeneic blood, and 19% of collected units were not used. For six common procedures, a 'target' autologous blood schedule of 2 or 3 units (depending on the procedure) was set. If an extra unit for each of 407 patients had been collected (i.e. 3 or 4), an additional 20 patients would have been protected from exposure to allogeneic blood at a cost of 387 unnecessary collections. The difference between the mean haemoglobin (Hb) concentration at entry to the programme and the mean pre-operative Hb concentration was not clinically important and only 25 of 511 patients were deferred on account of anaemia after one or more donations. The autologous blood used represents 3.8% of the units of blood or packed red blood cells transfused during the 2 years of study. Adverse (vasovagal) reactions were infrequent (2.2%) in spite of liberal acceptance criteria.
Pinkerton
P H
PH
Department of Laboratory Haematology, Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
D000740:Anemia / Q000097:blood / Q000209:etiology; D001771:Blood Banks; D016063:Blood Loss, Surgical; D001803:Blood Transfusion / Q000706:statistics & numerical data; D001804:Blood Transfusion, Autologous / Q000009:adverse effects / Q000706:statistics & numerical data; D000075202:Contraindications; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006785:Hospitals, University; D006801:Humans; D008297:Male; D009864:Ontario; D015397:Program Evaluation
D006454:Hemoglobins